Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

57.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.1K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

1.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trivalent ions kinetic-gating for producing high-concentration and shelf-stable plasmid DNA/PEI particles.

Nature communications·2026
Same author

Quantitative analysis of sequential nucleic acid elution from silica paramagnetic beads.

The Analyst·2026
Same author

A Multiplex Digital Polymerase Chain Reaction-Based Platform with a Unified Readout for Multiclass Biomarker Quantification from Low-Volume Blood.

ACS nano·2026
Same author

An unbiased approach to measure aberrant DNA methylation alterations.

Nature communications·2026
Same author

Rapid Bacteria Identification and Antimicrobial Susceptibility Testing via 5-Min Fluorescence In Situ Hybridization.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Buffer Valency Engineering Enables High-concentration and Shelf-stable DNA Transfection Particles for Viral Vector Production.

Research square·2025

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
10:16

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

1.9K

Applying biosensor development concepts to improve preamplification-free CRISPR/Cas12a-Dx.

Kuangwen Hsieh1, Guojie Zhao1, Tza-Huei Wang2

  • 1Department of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. thwang@jhu.edu.

The Analyst
|June 2, 2020
PubMed
Summary

Researchers optimized CRISPR/Cas12a-based diagnostics (Cas12a-Dx) without preamplification. This enhanced Cas12a-Dx sensitivity to 100 fM and reduced detection time to under 46 minutes.

More Related Videos

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
09:03

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

3.1K
Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
07:59

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System

Published on: April 25, 2025

1.0K

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
10:16

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

1.9K
Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
09:03

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

3.1K
Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
07:59

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System

Published on: April 25, 2025

1.0K

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Diagnostic Technology

Background:

  • CRISPR/Cas-based in vitro diagnostic devices (CRISPR/Cas-Dx) are a significant research area.
  • Cas12a enzyme-based diagnostics (Cas12a-Dx) are widely used for DNA target detection.
  • Current Cas12a-Dx research often emphasizes preamplification or advanced detection methods, potentially neglecting intrinsic capabilities.

Purpose of the Study:

  • To investigate and optimize the intrinsic detection capabilities of Cas12a-Dx without preamplification.
  • To systematically evaluate parameters influencing Cas12a-Dx sensitivity and reaction time.
  • To establish a baseline for improving Cas12a-Dx performance.

Main Methods:

  • Utilized a fluorescence-based Cas12a-Dx system as a test platform.
  • Systematically evaluated key reaction parameters: Cas12a enzyme, buffer composition, substrate labeling, substrate concentration, and temperature.
  • Focused on optimizing signal-to-background ratio and reaction kinetics.

Main Results:

  • Identified critical parameters for enhancing Cas12a-Dx performance.
  • Achieved a limit of detection (LOD) of 100 fM without preamplification.
  • Reduced the time-to-positive result to less than 46 minutes for the achieved LOD.

Conclusions:

  • Demonstrated significant improvements in Cas12a-Dx sensitivity and speed through parameter optimization.
  • Established a new benchmark for preamplification-free Cas12a-Dx performance.
  • Provided a foundational strategy for advancing Cas12a-Dx and other CRISPR/Cas-Dx technologies.